Benzinga

Benzinga

Benzinga

lundi, septembre 07

Alignment Healthcare Inc

ALHCNASDAQ
Trade with Public
Trade with Public
$13.54
-0.005-0.04%
À la clôture: Sep 4, 5:00 PM EST
$13.54
N/A
Après les heures: Sep 4, 4:00 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

Alignment Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alignment Healthcare (ALHC).

Price Target Range — 12 Quarters

Analyst Consensus — 11 Analysts

10Buy
1Hold
Consensus RatingOverweight# Analysts11Avg. Consensus PT$20Upside to Avg. PT+46.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 4, 2026JP MorganJohn StanselPT CutOverweight$26→$22
Aug 3, 2026Raymond JamesJohn RansomDowngradeStrong Buy→Outperform$22→$19
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and lowers the price target from $26 to $22.
Benzinga Newsdesk

PRO
Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19

Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Strong Buy to Outperform and lowers the price target from $22 to $19.
Benzinga Newsdesk

PRO
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $22

UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises the price target from $21 to $22.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Alignment Healthcare, Raises Price Target to $19

Barclays analyst Andrew Mok maintains Alignment Healthcare (NASDAQ:ALHC) with a Equal-Weight and raises the price target from $18 to $19.
Benzinga Newsdesk

6 Analysts Have This To Say About Alignment Healthcare

Benzinga Insights

PRO
JP Morgan Maintains Overweight on Alignment Healthcare, Raises Price Target to $26

JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and raises the price target from $23 to $26.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved